Plasma adrenomedullin is closely correlated with pulse wave velocity in middle-aged and elderly patients

Hypertension Research

Volumn 26, Issue 11, 2003, Pages 887-893

  Kita, Toshihiro ^a   Kitamura, Kazuo ^a   Hashida, Seiichi ^a   Morishita, Kazuhiro ^a   Eto, Tanenao ^a  

^a UNIVERSITY OF MIYAZAKI   (Japan)

Author keywords

Adrenomedullin; Arterial sclerosis; Endothelin; Pulse wave velocity

Indexed keywords

ADRENOMEDULLIN; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; NITRATE;

ADULT; AGE; AGED; ARTICLE; ATHEROSCLEROSIS; AUTOANALYZER; CARDIOVASCULAR RISK; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORRELATION FUNCTION; DISEASE MARKER; ENZYME IMMUNOASSAY; FEMALE; HEART FAILURE; HOSPITAL PATIENT; HUMAN; HYPERTENSION; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; MULTIVARIATE ANALYSIS; PROTEIN BLOOD LEVEL; PULSE WAVE; REGRESSION ANALYSIS; RISK ASSESSMENT; RISK FACTOR; STATISTICAL ANALYSIS; SYSTOLIC BLOOD PRESSURE; WAVEFORM;

ADRENOMEDULLIN; ADULT; AGED; ARTERIOSCLEROSIS; BIOLOGICAL MARKERS; FEMALE; HEART RATE; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGED; PEPTIDES; PULSE; RISK FACTORS;

EID: 0345099458     PISSN: 09169636     EISSN: None     Source Type: Journal    
DOI: 10.1291/hypres.26.887     Document Type: Article

References (28)

1. Laurent S, Boutouyrie P, Asmar R, et al: Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension 2001; 37: 1236-1241.
2. Blacher J, Asmar R, Djane S, London GM, Safar ME: Aortic pulse wave velocity as a marker of cardiovascular risk in hypertensive patients. Hypertension 1999; 33: 1111-1117.
3. Guerin AP, Blacher J, Pannier B, Marchais SJ, Safar ME, London GM: Impact of aortic stiffness attenuation on survival of patients in end-stage renal failure. Circulation 2001; 103: 987-992.
4. Eto T, Kitamura K, Kato J: Biological and clinical roles of adrenomedullin in circulation control and cardiovascular diseases. Clin Exp Pharmacol Physiol 1999; 26: 371-380.
5. Shimosawa T, Shibagaki Y, Ishibashi K, et al: Adrenomedullin, an endogenous peptide, counteracts cardiovascular damage. Circulation 2002; 105: 106-111.
6. Tsuruda T, Kato J, Kitamura K, et al: Adrenomedullin: a possible autocrine or paracrine inhibitor of hypertrophy of cardiomyocytes. Hypertension 1998; 31: 505-510.
7. Tsuruda T, Kato J, Kitamura K, et al: Enhanced adrenomedullin production by mechanical stretching in cultured rat cardiomyocytes. Hypertension 2000; 35: 1210-1214.
8. Saito T, Itoh H, Chun TH, et al: Coordinate regulation of endothelin and adrenomedullin secretion by oxidative stress in endothelial cells. Am J Physiol 2001; 281: H1364-H1371.
9. Suzuki E, Kashiwagi A, Nishio Y, et al: Increased arterial wall stiffness limits flow volume in the lower extremities in type 2 diabetic patients. Diabetes Care 2001; 24: 2107-2114.
10. Kubo T, Miyata M, Minagoe S, Setoyama S, Maruyama I, Tei C: A simple oscillometric technique for determining new indices of arterial distensibility. Hypertens Res 2002; 25: 351-358.
11. Yamashina A, Tomiyama H, Takeda K, et al: Validity, reproducibility, and clinical significance of noninvasive brachial-ankle pulse wave velocity measurement. Hypertens Res 2002; 25: 359-364.
12. Ohta H, Tsuji T, Asai S, et al: One-step direct assay for mature-type adrenomedullin with monoclonal antibodies. Clin Chem 1999; 45: 244-251.
13. Ohta H, Tsuji T, Asai S, et al: A simple immunoradiometric assay for measuring the entire molecules of adrenomedullin in human plasma. Clin Chim Acta 1999; 287: 131-143.
14. Ishikawa E, Imagawa M, Hashida S, Yoshitake S, Hamaguchi Y, Ueno T: Enzyme-labeling of antibodies and their fragments for enzyme immunoassay and immunohistochemical staining. J Immunoassay 1983; 44: 209-327.
15. Hashida S, Hashinaka K, Ishikawa E: Ultrasensitive enzyme immunoassay, in El-Gewely MR (ed): Biotechnology Annual Review. Volume 1. Amsterdam, Elsevier Science BV, 1995, pp 403-451.
16. Hashida S, Ishikawa E: Detection of one milliattomole of ferritin by novel and ultrasensitive enzyme immunoassay. J Biochem 1990; 108: 960-964.
17. Hashida S, Ishikawa S, Hashinaka K, Nishikata I, Oka S, Ishikawa E: Earlier detection of human immunodeficiency virus type 1 p24 antigen and immunoglobulin G and M antibodies to p17 antigen in seroconversion serum panels by immune complex transfer enzyme immunoassays. Clin Diag Lab Immunol 2000; 7: 872-881.
18. Elsasser TH, Kahl S: Adrenomedullin has multiple roles in disease stress: development and remission of the inflammatory response. Microsc Res Tech 2002; 57: 120-129.
19. Marutsuka K, Hatakeyama K, Sato Y, Yamashita A, Sumiyoshi A, Asada Y: Immunohistological localization and possible functions of adrenomedullin. Hypertens Res 2003; 26(Suppl): S33-S40.
20. Shinomiya K, Ohmori K, Ohyama H, et al: Association of plasma adrenomedullin with carotid atherosclerosis in chronic ischemic stroke. Peptides 2001; 22: 1873-1880.
21. Kohno M, Hanehira T, Kano H, et al: Plasma adrenomedullin concentrations in essential hypertension. Hypertension 1996; 27: 102-107.
22. Sumimoto T, Nishikimi T, Mukai M, et al: Plasma adrenomedullin concentrations and cardiac and arterial hypertrophy in hypertension. Hypertension 1997; 30: 741-745.
23. Kita T, Kitamura K, Kuwasako K, Kawamoto M, Eto T: Short-term modulation of the renin-angiotensin system does not alter plasma adrenomedullin concentration in humans. J Hypertens 1998; 16: 2057-2062.
24. Nakamura U, Iwase M, Nohara S, Kanai H, Ichikawa K, Iida M: Usefulness of brachial-ankle pulse wave velocity measurement: correlation with abdominal aortic calcification. Hypertens Res 2003; 26: 163-167.
25. Blacher J, Demuth K, Guerin AP, Safar ME, Moatti N, London GM: Influence of biochemical alterations on arterial stiffness in patients with end-stage renal disease. Arterioscler Thromb Vasc Biol 1998; 18: 535-541.
26. Kjaer A, Hesse B: Heart failure and neuroendocrine activation: diagnostic, prognostic and therapeutic perspectives. Clin Physiol 2001; 21: 661-672.
27. Kato J, Kitamura K, Uemura T, et al: Plasma levels of adrenomedullin and atrial and brain natriuretic peptides in the general population: their relations to age and pulse pressure. Hypertens Res 2002; 25: 887-892.
28. Benetos A, Adamopoulos C, Bureau JM, et al: Determinants of accelerated progression of arterial stiffness in normotensive subjects and in treated hypertensive subjects over a 6-year period. Circulation 2002; 105: 1202-1207.